Similar articles

• Questions raised by the failure of a trial of short-term psychodynamic therapy versus pharmacotherapy for major depressive disorder.

  Kocsis JH. Kocsis JH. J Clin Psychiatry. 2012 Jan;73(1):64-5. doi: 10.4088/JCP.11com07056. J Clin Psychiatry. 2012. PMID: 22316577 No abstract available.
• Journal Watch review of Short-term dynamic psychotherapy versus pharmacotherapy for major depressive disorder: a randomized, placebo-controlled trial.

  Jain S. Jain S. J Am Psychoanal Assoc. 2014 Feb;62(1):113-5. doi: 10.1177/0003065114525236. J Am Psychoanal Assoc. 2014. PMID: 24610762 No abstract available.
• Short-term dynamic psychotherapy versus pharmacotherapy for major depressive disorder: a randomized, placebo-controlled trial.

  Barber JP, Barrett MS, Gallop R, Rynn MA, Rickels K. Barber JP, et al. J Clin Psychiatry. 2012 Jan;73(1):66-73. doi: 10.4088/JCP.11m06831. Epub 2011 Nov 29. J Clin Psychiatry. 2012. PMID: 22152401 Clinical Trial.
• Clinically Useful Genetic Markers of Antidepressant Response: How Do We Get There From Here?

  McMahon FJ. McMahon FJ. Am J Psychiatry. 2015 Aug 1;172(8):697-9. doi: 10.1176/appi.ajp.2015.15050644. Am J Psychiatry. 2015. PMID: 26234589 No abstract available.
• Evidence base for the molecular underpinnings of psychodynamic psychotherapy.

  Alfonso CA. Alfonso CA. Psychodyn Psychiatry. 2012 Sep;40(3):533-5. doi: 10.1521/pdps.2012.40.3.533. Psychodyn Psychiatry. 2012. PMID: 23002708 Review. No abstract available.